HKU Scholars Hub: Browsing DSpace

Browsing by Author Amminger, GP

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中

or enter first few letters:

Showing results 1 to 13 of 13

	Title	Author(s)	Issue Date	Views
	Basic symptoms in young people at ultra-high risk of psychosis: Association with clinical characteristics and outcomes Journal:Schizophrenia Research	Youn, S Phillips, LJ Amminger, GP Berger, G Chen, EYH de Haan, L Hartmann, JA Hickie, IB Lavoie, S Markulev, C McGorry, PD Mossaheb, N Nieman, DH Nordentoft, M Riecher-Rössler, A Schäfer, MR Schlögelhofer, M Smesny, S Thompson, A Verma, S Yuen, HP Yung, AR Nelson, B	2020	16
	Cognitive functioning in ultra-high risk for psychosis individuals with and without depression: Secondary analysis of findings from the NEURAPRO randomized clinical trial Journal:Schizophrenia Research	Mallawaarachchi, SR Amminger, GP Farhall, J Bolt, LK Nelson, B Yuen, HP McGorry, PD Markulev, C Schäfer, MR Mossaheb, N Schlögelhofer, M Smesny, S Hickie, IB Berger, GE Chen, EYH de Haan, L Nieman, DH Nordentoft, M Riecher-Rössler, A Verma, S Thompson, A Yung, AR Allott, KA	2020	29
	Comparison of erythrocyte omega-3 index, fatty acids and molecular phospholipid species in people at ultra-high risk of developing psychosis and healthy people Journal:Schizophrenia Research	Alqarni, A Mitchell, TW McGorry, PD Nelson, B Markulev, C Yuen, HP Schäfer, MR Berger, M Mossaheb, N Schlögelhofer, M Smesny, S Hickie, IB Berger, GE Chen, EYH de Haan, L Nieman, DH Nordentoft, M Riecher-Rössler, A Verma, S Thompson, A Yung, AR Amminger, GP Meyer, BJ	2020	16
	Distress related to attenuated psychotic symptoms: Static and dynamic association with transition to psychosis, non-remission and transdiagnostic symptomatology in clinical high-risk patients in an international intervention trial Journal:Schizophrenia Bulletin Open	Nelson, B Yuen, HP Amminger, GP Berger, G Chen, EYH de Haan, L Hartmann, JA Hickie, IB Lavoie, S Markulev, C Mossaheb, N Nieman, DH Nordentoft, M Polari, A Riecher-Rössler, A Schäfe, MR Schlögelhofer, M Smesny, S Tedja, A Thompson, A Verma, S Yung, AR McGorry, PD	2020	15
	Do schizotypal or borderline personality disorders predict onset of psychotic disorder or persistent attenuated psychotic symptoms in patients at high clinical risk? Journal:Schizophrenia Research	Hadar, H Zhang, H Phillips, LJ Amminger, GP Berger, GE Chen, EYH de Haan, L Hartmann, JA Hickie, IB Lavoie, S Markulev, C McGorry, PD Mossaheb, N Nieman, DH Nordentoft, M Riecher-Rössler, A Schäfer, MR Schlögelhofer, M Smesny, S Thompson, A Verma, S Yuen, HP Yung, AR Nelson, B	2020	15
	International clinical practice guidelines for early psychosis Journal:British Journal of Psychiatry	Addington, J Amminger, GP Barbato, A Catts, S Chen, E Chhim, S Chong, SA Cullberg, J Edwards, J Grosso, L Louzã, M Hambrecht, M Keshavan, M Johannessen, JO Johnson, DL Lewis, S Lieberman, J Macewan, W Malla, A May, R Mcglashan, TH Mcgorry, P Merlo, MG Nordentoft, M Nightingale, S Perkins, D Thara, R Yamamoto, K Yung, A	2005	64
	Intervention in individuals at ultra-high risk for psychosis: A review and future directions Journal:Journal of Clinical Psychiatry	Mcgorry, PD Nelson, B Amminger, GP Bechdolf, A Francey, SM Berger, G RiecherRössler, A Klosterkötter, J Ruhrmann, S SchultzeLutter, F Nordentoft, M Hickie, I Mcguire, P Berk, M Chen, EYH Keshavan, MS Yung, AR	2009	40
	Neurocognition as a predictor of transition to psychotic disorder and functional outcomes in ultra-high risk participants: Findings from the NEURAPRO randomized clinical trial Journal:Schizophrenia Research	Bolt, LK Amminger, GP Farhall, J McGorry, PD Nelson, B Markulev, C Yuen, HP Schäfer, MR Mossaheb, N Schlögelhofer, M Smesny, S Hickie, IB Berger, GE Chen, EYH de Haan, L Nieman, DH Nordentoft, M Riecher-Rössler, A Verma, S Thompson, A Yung, AR Allott, KA	2019	11
	Omega‐3 fatty acids and neurocognitive ability in young people at ultra‐high risk for psychosis Journal:Early Intervention in Psychiatry	McLaverty, A Allott, KA Berger, M Hester, R McGorry, PD Nelson, B Markulev, C Yuen, HP Schäfer, MR Mossaheb, N Schlögelhofer, M Smesny, S Hickie, IB Berger, GE Chen, EYH de Haan, L Nieman, DH Nordentoft, M Riecher‐Rössler, A Verma, S Thompson, A Yung, AR Amminger, GP	2020	12
	Relationship Between Polyunsaturated Fatty Acids and Psychopathology in the NEURAPRO Clinical Trial Journal:Frontiers in Psychiatry	Berger, M Nelson, B Markulev, C Yuen, HP Schäfer, MR Mossaheb, N Schlögelhofer, M Smesny, S Hickie, IB Berger, GE Chen, EYH de Haan, L Nieman, DH Nordentoft, M Riecher-Rössler, A Verma, S Mitchell, TW Meyer, BJ Thompson, A Yung, AR McGorry, PD Amminger, GP	2019	13
	Supplementation with the omega-3 long chain polyunsaturated fatty acids: Changes in the concentrations of omega-3 index, fatty acids and molecular phospholipids of people at ultra high risk of developing psychosis Journal:Schizophrenia Research	Alqarni, A Mitchell, TW McGorry, PD Nelson, B Markulev, C Yuen, HP Schäfer, MR Berger, M Mossaheb, N Schlögelhofer, M Smesny, S Hickie, IB Berger, GE Chen, EYH Haan, L Nieman, DH Nordentoft, M Riecher-Rössler, A Verma, S Thompson, A Yung, AR Meyer, BJ Amminger, GP	2020	40
	The NEURAPRO Biomarker Analysis: Long-Chain Omega-3 Fatty Acids Improve 6-Month and 12-Month Outcomes in Youths at Ultra-High Risk for Psychosis Journal:Biological Psychiatry	Amminger, GP Nelson, B Markulev, C Yuen, HP Schäfer, MR Berger, M Mossaheb, N Schlögelhofer, M Smesny, S Hickie, IB Berger, GE Chen, EYH de Haan, L Nieman, DH Nordentoft, M Riecher-Rössler,, A Verma, S Thompson, A Yung, AR McGorry, PD	2020	11
	Trajectories of symptom severity and functioning over a three-year period in a psychosis high-risk sample: A secondary analysis of the Neurapro trial Journal:Behaviour Research and Therapy	Hartmann, JA Schmidt, SJ McGorry, PD Berger, M Berger, GE Chen, EYH de Haan, L Hickie, IB Lavoie, S Markule, C Mossaheb, N Nieman, DH Nordentoft, M Polari, A Riecher-Rössler, A Schäfer, MR Schlögelhofer, M Smesny, S Thompson, A Verma, SK Yuen, HP Yung, AR Amminger, GP Nelson, B	2020	15

Showing results 1 to 13 of 13